J, C., FI, S., CMAP, S., CF, L., JO, M., F, A., & AC, O. (2025). NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus aureus. Pharmaceutics, 17(6), . https://doi.org/10.3390/pharmaceutics17060799
Chicago Style (17th ed.) CitationJ, Carrasco-Rojas, Sandoval FI, Schuh CMAP, Lagos CF, Morales JO, Arriagada F, and Ortiz AC. "NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus Aureus." Pharmaceutics 17, no. 6 (2025). https://doi.org/10.3390/pharmaceutics17060799.
MLA (9th ed.) CitationJ, Carrasco-Rojas, et al. "NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus Aureus." Pharmaceutics, vol. 17, no. 6, 2025, https://doi.org/10.3390/pharmaceutics17060799.